zidovudine has been researched along with Graft vs Host Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arras, M; Boero, R; Carcassi, C; Contu, L; La Nasa, G; Ledda, A; OrrĂ¹, S; Pintus, A; Pizzati, A; Vacca, A | 1 |
Akaza, T; Hidaka, N; Juji, T; Nishimura, M; Tadokoro, K | 1 |
2 other study(ies) available for zidovudine and Graft vs Host Disease
Article | Year |
---|---|
Allogeneic bone marrow transplantation combined with multiple anti-HIV-1 treatment in a case of AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cyclophosphamide; Drug Therapy, Combination; Female; Graft vs Host Disease; Granulocyte-Macrophage Colony-Stimulating Factor; HIV-1; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Respiratory Distress Syndrome; Transplantation, Homologous; Zidovudine | 1993 |
Differential effect of azidothymidine on resting and activated cells: potentiality of this drug for treatment of post-transfusion graft-versus-host disease.
Topics: Anti-HIV Agents; CD8-Positive T-Lymphocytes; Cells, Cultured; Dose-Response Relationship, Drug; Fibroblasts; Graft vs Host Disease; Humans; Leukocytes, Mononuclear; Lymphocyte Activation; Phytohemagglutinins; Reverse Transcriptase Inhibitors; T-Lymphocytes, Cytotoxic; Transfusion Reaction; Zidovudine | 1998 |